“…Several cancers, including breast, lung, liver, prostate, stomach, colon, ovarian, pancreatic, and endometrial, have dysregulated MORC2 expression [57,58]. This increased expression of MORC2 is linked to cancer cell proliferation, metabolism, invasion, migration, and metastasis and confers chemotherapy resistance [15,[23][24][25]35,42,46,55,[57][58][59][60][61][62][63][64]. Furthermore, increased MORC2 expression levels were linked to poor prognosis and unfavorable clinical outcomes in non-small cell lung and breast cancer [58].…”